Traders Limelight— Cogentix Medical, Inc. (CGNT)

Cogentix Medical, Inc. (CGNT) added 0.26% with the finishing price of $3.85 in Friday Trading Session. With Latest positive move, stock price showed -1.79% lower in value from one year high price and revealed 148.39% higher in value from its one year low price. In the recent week Cogentix Medical, Inc. stock price volatility was noted 0.37% while for the last month volatility was seen at 0.72%. Its Average True Range (ATR) shows a number of 0.03. Return on assets (ROA) results to -1.20%. While Return on investment (ROI) reached to 3.60%. The -0.08% down picture painted by the trends generated around 20 SMAs. The established market sentiment toward the stock has created a trading environment which can suitably be described as pessimistic.

Laborie Medical Technologies (“Laborie”) announced the successful completion of the tender offer by its affiliate Camden Merger Sub, Inc. (“Merger Sub”), a wholly owned subsidiary of LM US Parent, Inc. (“Parent”) to purchase all outstanding shares of common stock of Cogentix Medical, Inc. (NASDAQ: CGNT) (“Cogentix“) for US$3.85 per share, net to the seller in cash without interest thereon and subject to any required withholding tax. The tender offer expired at 12:00 midnight, New York City time, at the end of Friday, April 20, 2018.

The depositary for the tender offer has advised Laborie that as of the expiration of the tender offer, approximately 51,490,083 shares have been validly tendered and not properly withdrawn in the tender offer (including 34,769 shares tendered through notices of guaranteed delivery), representing approximately 84.5 percent of Cogentix’s outstanding shares. Accordingly, the minimum tender condition for Laborie’s pending acquisition of Cogentix has been satisfied. As a result, Laborie accepted for payment in accordance with the terms of the tender offer all shares of Cogentix common stock that were validly tendered and not withdrawn prior to expiration of the tender offer (including all shares tendered through notices of guaranteed delivery), and payment for such shares will be made promptly. Laborie will complete the acquisition of Cogentix through a merger effected pursuant to Section 251(h) of the General Corporation Law of the State of Delaware without a vote or meeting of Cogentix’s stockholders. Laborie expects to effect the merger on or about April 23, 2018. In the merger, each outstanding share of Cogentix common stock not tendered and purchased in the Offer (excluding those shares for which holders properly exercised appraisal rights under Delaware law and those held by Cogentix) will be converted into the right to receive the same US$3.85 per share price, without interest and less any applicable withholding taxes, that was paid in the tender offer. As a result of the merger, Cogentix will become a wholly owned subsidiary of Parent. Following the merger, Cogentix’s common stock will be delisted and cease to be traded on the Nasdaq.

There has been up move seen around 50 SMAs. The stock price is showing 11.93% distance above 50 SMA. On the surface, it seems as the higher the 50-day moving average goes, the more bullish the market is (and the lower it goes, the more bearish). In practice, however, the reverse is true. The 50-day moving average is perceived to be the dividing line between a stock that is technically healthy and one that is not. Furthermore, the percentage of stocks above their 50-day moving average helps determine the overall health of the market. Many market traders also use moving averages to determine profitable entry and exit points into specific securities.

Cogentix Medical, Inc. (CGNT) has demonstrated up trend based on recent movement of 200 SMA with 37.36% during the course of recent market activity. This trend reveals recent direction. The current direction of 200 SMA is upward. When the price over the last 200 days is moving with increasing trend, look for buy opportunities and when it shows decreasing trend the price is below the last 200 days, look for sell opportunities.

The current value of the RSI is 69.88. The relative strength index (RSI) readings highlights overbought above 70 and oversold below 30. The stock also has a beta of 0.56. When beta is less/more than 1, it can be interpreted that the stock is theoretically less/more volatile than the market – something traders will surely be keeping an eye on.

In terms of profitability, The Company has a profit margin of -1.60%, gross margin of 66.50% and an operating of -1.40%. The stock price changed 0.26% in the past week. Shares of the company have performed 37.50% over the last three months and moved 140.63% over the last 12- months.

Analysts contributed mean rating at 2.7. This recommendation scale based between 1 and 5. Analysts offer the company with a rating of 3 would be a sign of a Hold rating. Analysts pass on shares a rating of 1 or 2 would be signifying a Buy. A rating of 4 or 5 would tip to a Sell suggestion.

Leave a Reply

Your email address will not be published. Required fields are marked *